Arthroscopic and Sport Medical Center, New Sassuolo Hospital, Via Francesco Ruini 2, 41049 Sassuolo, MO, Italy.
J Orthop Traumatol. 2013 Jun;14(2):109-14. doi: 10.1007/s10195-013-0229-z. Epub 2013 Mar 1.
Loss of motion of the elbow joint is a common finding after elbow trauma. It has been shown that arthroscopic treatment leads to excellent restoration of elbow motion, although it is still a demanding procedure. The aim of our cohort study was to assess clinical outcomes following treatment of posttraumatic elbow stiffness using arthroscopic arthrolysis with or without the associated use of a hyaluronan anti-adhesion gel.
A cohort of 36 consecutive patients undergoing elbow arthroscopic arthrolysis were enrolled: 17 patients in the hyaluronan gel group and 19 in the control group. The patients underwent prospective control visits 30 and 75 days after surgery. Functional outcome was measured by the range of motion and the Liverpool elbow score (LES), whereas pain and quality of life were evaluated using the visual analogue scale and the SF-36 questionnaire, respectively.
The range of motion and the overall LES score increased over time in both groups. The mean increase over time was statistically significant (p < 0.001) in both groups and there was no difference between the groups. There was also no interaction between time and treatment. The percentage of patients who reported pain decreased significantly over time (p = 0.0419) in the hyaluronan-treated group (suggesting limited contractions and better comfort during rehabilitation), but not in the control group. The intensity of pain decreased significantly over time in both groups (p < 0.0001) without any significant difference between the groups. All the changes in patient quality of life as measured by the SF-36 questionnaire were similar for the two groups of patients. No adverse event or complication related to the application of hyaluronan gel occurred.
Our preliminary clinical experience showed promising results upon the use of hyaluronan gel, considering that it significantly reduced pain in the short term, facilitating a more comfortable rehabilitation. These findings should be confirmed by larger studies.
肘部创伤后,关节运动丧失是常见的表现。关节镜治疗可显著恢复肘部运动,尽管这仍是一个要求较高的手术。我们的队列研究旨在评估关节镜下松解术治疗创伤后肘部僵硬的临床疗效,包括是否联合使用透明质酸防粘连凝胶。
我们纳入了 36 例接受肘部关节镜下松解术的连续患者:透明质酸凝胶组 17 例,对照组 19 例。患者分别在术后 30 天和 75 天进行前瞻性对照访视。通过活动范围和利物浦肘部评分(LES)评估功能结果,通过视觉模拟评分和 SF-36 问卷评估疼痛和生活质量。
两组的活动范围和整体 LES 评分均随时间推移而增加。两组的平均增加均具有统计学意义(p<0.001),且两组之间无差异。时间与治疗之间也没有相互作用。透明质酸凝胶治疗组报告疼痛的患者百分比随时间显著下降(p=0.0419),提示康复期间的限制收缩和更好的舒适度,但对照组无此变化。两组的疼痛强度均随时间显著下降(p<0.0001),且两组之间无显著差异。SF-36 问卷评估的所有患者生活质量变化在两组之间均相似。使用透明质酸凝胶未发生任何与凝胶应用相关的不良事件或并发症。
我们的初步临床经验表明,使用透明质酸凝胶具有前景,因为它可在短期内显著减轻疼痛,促进更舒适的康复。这些发现需要更大的研究来证实。